Prostate Cancer - Results from #1460

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. January 23, 2024

Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review. January 23, 2024

Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients. January 23, 2024

Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis. January 23, 2024

The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. January 22, 2024

Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers. January 22, 2024

Palliative urologic surgery for metastatic prostate cancer: what needs to be considered in the future?. January 22, 2024

DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. January 22, 2024

The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: a national population-based evaluation. January 22, 2024

Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. January 22, 2024

Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer Patients. January 22, 2024

Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis. January 22, 2024

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. January 19, 2024

Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making. January 19, 2024

Identification of Plausible Candidates in Prostate Cancer Using Integrated Machine Learning Approaches. January 19, 2024

Exploiting the DNA Damage Response for Prostate Cancer Therapy. January 19, 2024

Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes. January 19, 2024

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings. January 19, 2024

Decreased Opioid Use and Equivalent Pain Score Outcomes After Robotic Urologic Surgery Using a Simplified Opioid Minimization Protocol: A Safety-Net Hospital Experience January 19, 2024

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer. January 18, 2024

Page 74 of 1435